New Data on Diagnostic and Therapeutic Applications of ThyroSeq® Genomic Classifier Presented at the 2019 American Association of Clinical Endocrinologists Annual Meeting

AUSTIN, Texas, April 26, 2019 /PRNewswire/ -- Data from three studies demonstrating new diagnostic and therapeutic utility of ThyroSeq® Genomic Classifier, offered commercially by CBLPath, a Sonic Healthcare Company, are being presented at the 28th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (AACE) in Los Angeles, California.

For more information and full story, visit

https://www.prnewswire.com/news-releases/new-data-on-diagnostic-and-therapeutic-applications-of-thyroseq-genomic-classifier-presented-at-the-2019-american-association-of-clinical-endocrinologists-annual-meeting-300839022.html